Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback